Clinical Chemistry Phenobarbital, list number 1E08
Published April 24, 2013 · Recall initiated: November 16, 2012
Summary
FDA records medical device Class II recall Z-1118-2013, published April 24, 2013 and initiated November 16, 2012. Recalling firm: Abbott Laboratories, Inc; Status: Terminated; Reported quantity: 1289; Lot: Lot Numbers 52803UN12, 62299UN12, and 85773UN12. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Abbott Diagnostics is recalling Clinical Chemistry Phenobarbital reagent lots 62299UN12 and 85773UN12 due to imprecision issues which increase with the age of the reagent lot. The imprecision of the Phenobarbital assay is d 7% Total CV%; however, internal testing confirmed CVs up to approximately 12% for in-date reagent lots over five months old. Although lot 52803UN12 is now expired, it exhibit
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Abbott Laboratories, Inc
- Distributor
- Worldwide Distribution - USA (nationwide) and Internationally to Internationally distributed to Argentina, Australia, Austria, Bahamas, Brunei, Canada, Chile, Curacao, Denmark, France, Germany, Greece, Ireland, Italy, Lebanon, Mexico, Netherlands, Norway, Oman, Paraguay, Portugal, Puerto Rico, Russia, Saudi Arabia, Serbia, South Korea, Spain, Switzerland, Turkey, and United Kingdom.
- Lot
- Lot Numbers 52803UN12, 62299UN12, and 85773UN12
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAAlinity s System REF 06P16-01. An automated immunoassay analyzer for In Vitro diagnostic use in blood donorAugust 18, 2021
- FDAARCHITECT C System Mixer - Product Usage: The ARCHITECT Clinical Chemistry System is designed to performApril 15, 2020
- FDAC4 is an in vitro diagnostic assay for the quantitative determination of C4 in human serum or plasma. AntigenJuly 31, 2019
- FDAARCHITECT c4000 part number 02P24; ARCHITECT c8000 part number 01G06; ARCHITECT c16000 part number 03L77November 29, 2017
- FDAThe GemStar Pump is a small and lightweight, single channel infusion device designed for use in the home, inApril 24, 2013
- FDAADVIA Centaur Vitamin D Assay (100 tests); Reference Number: 10491994. For use in the quantitativeApril 24, 2013
Questions about this recall
Was Clinical Chemistry Phenobarbital, list number 1E08 recalled?
Yes. FDA published recall Z-1118-2013 on April 24, 2013. Reported hazard: Abbott Diagnostics is recalling Clinical Chemistry Phenobarbital reagent lots 62299UN12 and 85773UN12 due to imprecision issues which increase with the age of the reagent lot. The imprecision of the Phenobarbital assay is d 7% Total CV%; however, internal testing confirmed CVs up to approximately 12% for in-date reagent lots over five months old. Although lot 52803UN12 is now expired, it exhibit
What should I do if I have this product?
Voluntary: Firm initiated · Letter